Compare LH & DLTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LH | DLTR |
|---|---|---|
| Founded | 1971 | 1986 |
| Country | United States | United States |
| Employees | 70000 | N/A |
| Industry | Medical Specialities | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.9B | 24.4B |
| IPO Year | 2005 | 1996 |
| Metric | LH | DLTR |
|---|---|---|
| Price | $322.50 | $129.00 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 18 |
| Target Price | ★ $311.33 | $123.35 |
| AVG Volume (30 Days) | 762.6K | ★ 2.3M |
| Earning Date | 04-30-2026 | 06-03-2026 |
| Dividend Yield | ★ 1.12% | N/A |
| EPS Growth | 18.33 | ★ 144.33 |
| EPS | ★ 6.99 | 1.76 |
| Revenue | $13,951,700,000.00 | ★ $19,411,800,000.00 |
| Revenue This Year | $8.26 | $8.48 |
| Revenue Next Year | $4.81 | $5.90 |
| P/E Ratio | ★ $45.87 | $73.84 |
| Revenue Growth | 7.25 | ★ 10.43 |
| 52 Week Low | $244.52 | $84.71 |
| 52 Week High | $321.34 | $142.40 |
| Indicator | LH | DLTR |
|---|---|---|
| Relative Strength Index (RSI) | 72.45 | 57.68 |
| Support Level | $252.81 | $117.29 |
| Resistance Level | N/A | $132.87 |
| Average True Range (ATR) | 8.56 | 3.17 |
| MACD | 1.13 | -0.17 |
| Stochastic Oscillator | 97.70 | 79.65 |
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
Founded in 1986, Dollar Tree operates almost 9,000 small-box discount stores across the United States and Canada, offering roughly 85% of its merchandise under $2. The chain targets value-conscious suburban and urban shoppers with a mix of consumables (49% of sales), variety (45%), and seasonal goods (6%). In fiscal 2025, Dollar Tree generated over $19 billion in sales, through its multi-price strategy, higher-margin discretionary assortments, and private-label products that account for nearly one-third of sales.